{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:23:12Z","timestamp":1761578592636},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","heartandlung.org","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart & Lung"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.hrtlng.2015.02.006","type":"journal-article","created":{"date-parts":[[2015,3,10]],"date-time":"2015-03-10T05:48:30Z","timestamp":1425966510000},"page":"209-211","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["A sanguineous pleuro pericardial effusion in a patient recently treated with Dabigatran"],"prefix":"10.1016","volume":"44","author":[{"given":"Mokhtar","family":"Abdallah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidal","family":"Abi Rafeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georges","family":"Khoueiry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Abouyassine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Chalhoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dany","family":"Elsayegh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Sasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrtlng.2015.02.006_bib1","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1161\/CIR.0b013e31820f14c0","article-title":"2011 ACCF\/AHA\/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice guidelines","volume":"123","author":"Samuel Wann","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hrtlng.2015.02.006_bib2","unstructured":"Pradaxa [Prescribing Information]. Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals, Inc."},{"key":"10.1016\/j.hrtlng.2015.02.006_bib3","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.hrtlng.2015.02.006_bib4","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa0906598","article-title":"Dabigatran versus warfarin in the treatment of acute venous thromboembolism","volume":"361","author":"Schulman","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.hrtlng.2015.02.006_bib5","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/CIRCULATIONAHA.113.004450","article-title":"Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis","volume":"129","author":"Schulman","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hrtlng.2015.02.006_bib6","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1161\/CIRCULATIONAHA.111.029017","article-title":"Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects","volume":"124","author":"Eerenberg","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hrtlng.2015.02.006_bib7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/08998280.2005.11928030","article-title":"Pericardial heart disease: its morphologic features and its causes","volume":"18","author":"Roberts","year":"2005","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"10.1016\/j.hrtlng.2015.02.006_bib8","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1056\/NEJM196504012721305","article-title":"Anticoagulant-induced hemopericardium with tamponade \u2014 its occurrence in the absence of myocardial infarction or pericarditis","volume":"272","author":"Fel","year":"1965","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.hrtlng.2015.02.006_bib9","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1002\/j.1875-9114.2012.01036.x","article-title":"Hemopericardium in a patient treated with dabigatran etexilate","volume":"32","author":"Barton","year":"2012","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.hrtlng.2015.02.006_bib10","unstructured":"Propafenone [Drug Information]. Lexicomp, Inc."},{"issue":"2","key":"10.1016\/j.hrtlng.2015.02.006_bib11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.amjopharm.2012.02.004","article-title":"Clinical challenges in a patient with dabigatran-induced fatal hemorrhage","volume":"10","author":"Cano","year":"2012","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.hrtlng.2015.02.006_bib12","first-page":"7","article-title":"Aspirin\/Dabigatran etexilate\/propafenone interaction","volume":"1408","year":"2012","journal-title":"React Wkly"},{"key":"10.1016\/j.hrtlng.2015.02.006_bib13","first-page":"1","article-title":"Monitoring and reversal strategies for new oral anticoagulants","author":"Vanden Daelen","year":"2014","journal-title":"Expert Rev Cardiovasc Ther"}],"container-title":["Heart & Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956315000527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956315000527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T09:24:44Z","timestamp":1539681884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147956315000527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0147956315000527"],"URL":"https:\/\/doi.org\/10.1016\/j.hrtlng.2015.02.006","relation":{},"ISSN":["0147-9563"],"issn-type":[{"value":"0147-9563","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A sanguineous pleuro pericardial effusion in a patient recently treated with Dabigatran","name":"articletitle","label":"Article Title"},{"value":"Heart & Lung","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrtlng.2015.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}